Human versus porcine mesenchymal stromal cells: Phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 8, 2012, Pages 1827-1839

  Noort, W A ^a,b   Oerlemans, M I F J ^a   Rozemuller, H ^a   Feyen, D ^a   Jaksani, S ^a,b   Stecher, D ^a   Naaijkens, B ^a   Martens, A C ^a   Buhring H J ^c   Doevendans, P A ^a,b   Sluijter, J P G ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CD271+ cells; Cellular therapy; HMSC; Immunomodulation; Myocardial infarction; PMSC

Indexed keywords

LEUKOCYTE ANTIGEN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CHONDROGENESIS; COMPARATIVE STUDY; CYTOLOGY; FLOW CYTOMETRY; HEART FUNCTION TEST; HEART MUSCLE; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; MOUSE MUTANT; OSTEOBLAST; PATHOLOGY; PHENOTYPE; SWINE; T LYMPHOCYTE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CHONDROGENESIS; FLOW CYTOMETRY; HEART FUNCTION TESTS; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, SCID; MYOCARDIUM; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; SUS SCROFA; T-LYMPHOCYTES;

SUIDAE; SUS;

EID: 84864386301     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01455.x     Document Type: Article

References (50)

1. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008; 451: 937-42.
2. van Ramshorst J, Bax JJ, Beeres SL, et al Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA. 2009; 301: 1997-2004.
3. Chen SL, Fang WW, Ye F, et al Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 92-5.
4. Chen S, Liu Z, Tian N, et al Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol. 2006; 18: 552-6.
5. Katritsis DG, Sotiropoulou PA, Karvouni E, et al Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005; 65: 321-9.
6. Abdel-Latif A, Bolli R, Tleyjeh IM, et al Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167: 989-97.
7. van der Spoel TI, Jansen Of Lorkeers SJ, Agostoni P, et al Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease. Cardiovasc Res. 2011; 91: 649-58.
8. Burchfield JS, Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair. 2008; 1: 4.
9. Benvenuto F, Ferrari S, Gerdoni E, et al Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells. 2007; 25: 1753-60.
10. Nesselmann C, Ma N, Bieback K, et al Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008; 12: 1795-810.
11. Satija NK, Singh VK, Verma YK, et al Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 2009; 13: 4385-402.
12. Wen Z, Zheng S, Zhou C, et al Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011; 15: 1032-43.
13. Vrijsen KR, Sluijter JP, Schuchardt MW, et al Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med. 2010; 14: 1064-70.
14. Shake JG, Gruber PJ, Baumgartner WA, et al Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002; 73: 1919-25.
15. Amado LC, Schuleri KH, Saliaris AP, et al Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol. 2006; 48: 2116-24.
16. Halkos ME, Zhao ZQ, Kerendi F, et al Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol. 2008; 103: 525-36.
17. Dominici M, Le BK, Mueller I, et al Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
18. Di Nicola M, Carlo-Stella C, Magni M, et al Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99: 3838-43.
19. Le Blanc K, Frassoni F, Ball L, et al Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371: 1579-86.
20. Le Blanc K, Rasmusson I, Sundberg B, et al Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004; 363: 1439-41.
21. Ball LM, Bernardo ME, Roelofs H, et al Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007; 110: 2764-7.
22. Quirici N, Soligo D, Bossolasco P, et al Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002; 30: 783-91.
23. Battula VL, Treml S, Bareiss PM, et al Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2009; 94: 173-84.
24. Buhring HJ, Battula VL, Treml S, et al Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci. 2007; 1106: 262-71.
25. Noort WA, Kruisselbrink AB, in't Anker PS, et al Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002; 30: 870-8.
26. Dang ZC, van Bezooijen RL, Karperien M, et al Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res. 2002; 17: 394-405.
27. Pittenger MF, Mackay AM, Beck SC, et al Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
28. Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc. 2007; 2: 2049-56.
29. Oerlemans MI, Goumans MJ, van MB, et al Active Wnt signaling in response to cardiac injury. Basic Res Cardiol. 2010; 105: 631-41.
30. Smits AM, van Laake LW, den OK, et al Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res. 2009; 83: 527-35.
31. van Laake LW, Passier R, Monshouwer-Kloots J, et al Monitoring of cell therapy and assessment of cardiac function using magnetic resonance imaging in a mouse model of myocardial infarction. Nat Protoc. 2007; 2: 2551-67.
32. Arslan F, Smeets MB, O'Neill LA, et al Myocardial ischemiaya/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation. 2010; 121: 80-90.
33. Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood. 1991; 78: 55-62.
34. Battula VL, Bareiss PM, Treml S, et al Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation. 2007; 75: 279-91.
35. Krause U, Harter C, Seckinger A, et al Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev. 2007; 16: 31-7.
36. Grogaard HK, Sigurjonsson OE, Brekke M, et al Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion. Cardiovasc Revasc Med. 2007; 8: 21-7.
37. Peister A, Mellad JA, Larson BL, et al Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004; 103: 1662-8.
38. Moscoso I, Centeno A, Lopez E, et al Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant Proc. 2005; 37: 481-2.
39. Thomson BM, Bennett J, Dean V, et al Preliminary characterization of porcine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexamethasone, transforming growth factor beta, and basic fibroblast growth factor. J Bone Miner Res. 1993; 8: 1173-83.
40. Ringe J, Kaps C, Schmitt B, et al Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res. 2002; 307: 321-7.
41. Rozemuller H, Prins HJ, Naaijkens B, et al Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies. Stem Cells Dev. 2010; 19: 1911-21.
42. Post S, Abdallah BM, Bentzon JF, et al Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone. 2008; 43: 32-9.
43. Simmons PJ, Torok-Storb B. CD34 expression by stromal precursors in normal human adult bone marrow. Blood. 1991; 78: 2848-53.
44. Gronthos S, Zannettino AC, Hay SJ, et al Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003; 116: 1827-35.
45. Jones EA, Kinsey SE, English A, et al Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 2002; 46: 3349-60.
46. Boiret N, Rapatel C, Veyrat-Masson R, et al Characterization of nonexpanded mesenchymal progenitor cells from normal adult human bone marrow. Exp Hematol. 2005; 33: 219-25.
47. Ramasamy R, Lam EW, Soeiro I, et al Mesenchymal stem cells inhibit proliferation and apoptosis of tumour cells: impact on in vivo tumour growth. Leukemia. 2007; 21: 304-10.
48. Poncelet AJ, Vercruysse J, Saliez A, et al Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation. 2007; 83: 783-90.
49. Makino S, Fukuda K, Miyoshi S, et al Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999; 103: 697-705.
50. Toma C, Pittenger MF, Cahill KS, et al Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105: 93-8.